A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines

Project Information

UniVax

Grant agreement ID: 601738

Project closed

Start date 1 October 2013

End date 30 September 2018

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 803 864,40

EU contribution € 5 999 457,00

Coordinated by

EIDGENOESSISCHES DEPARTEMENT DES INNERN
Switzerland